StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)

Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%

Bio-Techne free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Bio-Techne's free cash flow for the twelve months ending Jun 30, 2026 was $263.22M, up 2.6% year over year. For fiscal 2026 it was $263.22M, up 2.6% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $307.86M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$263.22M+2.6%
FY2025Jun 30, 2025$256.55M+8.7%
FY2024Jun 30, 2024$236.10M+9.2%
FY2023Jun 30, 2023$216.15M-22.9%
FY2022Jun 30, 2022$280.36M-8.9%
FY2021Jun 30, 2021$307.86M+100.6%
FY2020Jun 30, 2020$153.47M-1.8%
FY2019Jun 30, 2019$156.21M+4.5%
FY2018Jun 30, 2018$149.43M+16.3%
FY2017Jun 30, 2017$128.54M+1.0%
FY2016Jun 30, 2016$127.26M+6.5%
FY2015Jun 30, 2015$119.45M-2.8%
FY2014Jun 30, 2014$122.94M+21.6%
FY2013Jun 30, 2013$101.11M-16.3%
FY2012Jun 30, 2012$120.73M-2.3%
FY2011Jun 30, 2011$123.56M+15.9%
FY2010Jun 30, 2010$106.62M+1.8%
FY2009Jun 30, 2009$104.77M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$86.94M-6.8%
Q3 FY2026CQ1 2026Mar 31, 2026$77.58M+150.3%
Q2 FY2026CQ4 2025Dec 31, 2025$76.49M-1.3%
Q1 FY2026CQ3 2025Sep 30, 2025$22.22M-59.4%
Q4 FY2025CQ2 2025Jun 30, 2025$93.31M+62.2%
Q3 FY2025CQ1 2025Mar 31, 2025$31.00M-52.0%
Q2 FY2025CQ4 2024Dec 31, 2024$77.53M+13.6%
Q1 FY2025CQ3 2024Sep 30, 2024$54.72M+19.5%
Q4 FY2024CQ2 2024Jun 30, 2024$57.52M-20.7%
Q3 FY2024CQ1 2024Mar 31, 2024$64.55M+66.4%
Q2 FY2024CQ4 2023Dec 31, 2023$68.25M+17.1%
Q1 FY2024CQ3 2023Sep 30, 2023$45.79M-1.6%
Q4 FY2023CQ2 2023Jun 30, 2023$72.56M-18.6%
Q3 FY2023CQ1 2023Mar 31, 2023$38.79M-33.2%
Q2 FY2023CQ4 2022Dec 31, 2022$58.28M-35.8%
Q1 FY2023CQ3 2022Sep 30, 2022$46.53M+9.8%
Q4 FY2022CQ2 2022Jun 30, 2022$89.15M-19.5%
Q3 FY2022CQ1 2022Mar 31, 2022$58.03M-9.7%
Q2 FY2022CQ4 2021Dec 31, 2021$90.83M+16.7%
Q1 FY2022CQ3 2021Sep 30, 2021$42.36M-23.1%
Q4 FY2021CQ2 2021Jun 30, 2021$110.70M+303.8%
Q3 FY2021CQ1 2021Mar 31, 2021$64.26M+59.9%
Q2 FY2021CQ4 2020Dec 31, 2020$77.82M+39.3%
Q1 FY2021CQ3 2020Sep 30, 2020$55.07M+83.5%
Q4 FY2020CQ2 2020Jun 30, 2020$27.42M-38.0%
Q3 FY2020CQ1 2020Mar 31, 2020$40.19M+15.7%
Q2 FY2020CQ4 2019Dec 31, 2019$55.85M+33.1%
Q1 FY2020CQ3 2019Sep 30, 2019$30.01M-14.9%
Q4 FY2019CQ2 2019Jun 30, 2019$44.25M-25.0%
Q3 FY2019CQ1 2019Mar 31, 2019$34.74M+91.5%
Q2 FY2019CQ4 2018Dec 31, 2018$41.96M+27.7%
Q1 FY2019CQ3 2018Sep 30, 2018$35.26M-10.6%
Q4 FY2018CQ2 2018Jun 30, 2018$59.02M+31.2%
Q3 FY2018CQ1 2018Mar 31, 2018$18.14M-13.6%
Q2 FY2018CQ4 2017Dec 31, 2017$32.85M-14.7%
Q1 FY2018CQ3 2017Sep 30, 2017$39.42M+63.9%
Q4 FY2017CQ2 2017Jun 30, 2017$44.98M–
Q3 FY2017CQ1 2017Mar 31, 2017$21.00M–
Q2 FY2017CQ4 2016Dec 31, 2016$38.50M–
Q1 FY2017CQ3 2016Sep 30, 2016$24.06M–

More Bio-Techne figures

See a number that looks wrong?